Heart flutters: which treatment works best?

NCT ID NCT07445334

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study compares two treatments for premature ventricular complexes (PVCs) — extra heartbeats that can cause symptoms. One treatment is catheter ablation, a procedure that destroys the tiny spot causing the extra beats. The other is medication to control the rhythm. The study will enroll 40 adults with frequent PVCs and follow them for 6 months to see which approach better reduces symptoms and improves quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
catheter ablation (a procedure that destroys the tiny area of heart tissue causing extra beats) and anti-arrhythmic drugs (medication to control heart rhythm)
What this could lead to
If this pilot succeeds, it could point toward a more effective treatment for PVCs, potentially reducing symptoms and improving quality of life without lifelong medication.
What could go wrong
This is a very small pilot study (40 people) that hasn't started yet. It may not show a clear winner, and results may not apply to everyone with PVCs. Catheter ablation carries risks like bleeding or heart damage.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PREMATURE VENTRICULAR BEATS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Ventricular Premature Complexes

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Westmead Hospital

    Westmead, New South Wales, 2017, Australia

More trials for these conditions

Other studies related to the condition(s) this trial covers.